Cargando…
The Role of Geranylgeraniol in Managing Bisphosphonate-Related Osteonecrosis of the Jaw
Medication-related osteonecrosis of the jaw (ONJ) is a rare but significant adverse side effect of antiresorptive drugs. Bisphosphonate-related ONJ (BRONJ) is the most prevalent condition due to the extensive use of the drug in cancer and osteoporosis treatment. Nitrogen-containing bisphosphonates s...
Autores principales: | Chin, Kok-Yong, Ekeuku, Sophia Ogechi, Trias, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114760/ https://www.ncbi.nlm.nih.gov/pubmed/35600875 http://dx.doi.org/10.3389/fphar.2022.878556 |
Ejemplares similares
-
Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
por: Chen, Xin, et al.
Publicado: (2021) -
Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients
por: Jung, Sung-mok, et al.
Publicado: (2018) -
Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Chin, Kok-Yong, et al.
Publicado: (2023) -
Bisphosphonate-related osteonecrosis of the jaws (Bronj)
por: Beninati, Francesco, et al.
Publicado: (2013) -
Bisphosphonate-Related Osteonecrosis of the Jaw: Specificities
por: Paulo, Siri, et al.
Publicado: (2014)